A new report filed with the New York legislature by state cannabis regulators on Oct. 1 paints a picture of a continually growing legal market that has reached nearly $654 million in sales, but which has also apparently left more than 200 “justice-involved” retail license holders in limbo. The wide-ranging …
“These results highlight the potential of CBD as a novel treatment for psychosis,” investigators concluded. The post Clinical Trial: CBD Mitigates Symptoms in Patients at Clinically High Risk for Psychosis appeared first on NORML.
Seventy-one percent of patients and 59 percent of pain specialists supported the “federal legalization of medical cannabis.” The post Survey: Majority of Pain Physicians Favor Federal Legalization of Medical Cannabis appeared first on NORML.
Marijuana-related investigations far outnumbered those triggered by allegations of maternal tobacco or alcohol use. The post Report: Allegations of Marijuana Use Frequently Trigger CPS Investigations appeared first on NORML.